Rejano, Baby Boy .
HRN: 25-67-95 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/30/2024
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
10/30/2024
11/05/2024
IV
40
Q24
T/C MAS
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes